Structure-based drug design for dopamine D3 receptor

Combinatorial Chemistry & High Throughput Screening
Zhiwei FengYouyong Li

Abstract

D2-like receptors are members of dopamine receptors, including dopamine D2 receptor (D2R), dopamine D3 receptor (D3R), and dopamine D4 receptor (D4R), which modulate behavior, cognition, and emotion. D2-like receptors are critical targets for drug development. Particularly, D3R has been identified as a therapeutic target for antipsychotic and anti-parkinsonian drugs. Recently, the crystal structure of D3R was reported. Here we summarize the available active compounds for D3R and the structure-activity relationships (SAR) studies of them. This provides lead templates for further chemical modification. We describe the structure features of the recent crystal structure of D3R and its difference from other G protein-coupled receptors (GPCRs). We provide the recognition mechanism of the inhibitors of D3R (molecular docking results and molecular dynamics results), which illustrates the interaction between the inhibitors and critical residues of D3R. Finally, we summarize the outlook of drug development for D3R. Our study provides useful information for developing high selective, high potent antagonists and agonists of D3R.

Related Concepts

Drug Development
Molecular Dynamics
Pyrazoles
Pyridines
Thiophenes
Dopamine D4 receptor
Dopamine D3 receptor
Combinatorial Chemistry Techniques
Structure-Activity Relationship
Piperazines

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Receptor and Signal Transduction Research
Amina S Woods
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Nathalie GriffonA Mann
© 2020 Meta ULC. All rights reserved